简介：
Overview
This protocol describes an automated, ISO15189-accredited next-generation sequencing workflow for detecting targetable genomic alterations in non-small cell lung cancer (NSCLC) formalin-fixed paraffin-embedded tissues. The process includes sample registration, sectioning, and nucleic acid extraction.
Key Study Components
Area of Science
- Oncology
- Genomics
- Pathology
Background
- Non-small cell lung cancer (NSCLC) is a common type of lung cancer.
- Identifying genomic alterations is crucial for targeted therapies.
- Formalin-fixed paraffin-embedded tissues are often used in cancer research.
- Automated workflows can enhance efficiency and accuracy in genomic testing.
Purpose of Study
- To establish a reliable sequencing workflow for NSCLC samples.
- To improve the detection of targetable genomic alterations.
- To ensure compliance with ISO15189 standards.
Methods Used
- Register sample information in the Laboratory Information Management System.
- Cut sections from formalin-fixed paraffin-embedded samples using microtome blades.
- Perform routine hematoxylin and eosin staining to evaluate tumor cell content.
- Extract nucleic acids using an automated extraction instrument.
Main Results
- Successful extraction of nucleic acids from NSCLC samples.
- High-quality genomic data obtained for targetable alterations.
- Workflow demonstrated compliance with ISO15189 accreditation.
- Improved diagnostic capabilities for NSCLC treatment.
Conclusions
- The automated sequencing workflow is effective for NSCLC.
- Compliance with ISO15189 enhances the reliability of results.
- This protocol can be adapted for other cancer types.
What is the significance of ISO15189 accreditation?
ISO15189 accreditation ensures that the laboratory meets international standards for quality and competence in medical testing.
How are genomic alterations detected in this workflow?
Genomic alterations are detected through next-generation sequencing of extracted nucleic acids from cancer tissue samples.
What types of samples can be used?
Formalin-fixed paraffin-embedded tissues from non-small cell lung cancer are primarily used in this protocol.
What is the role of hematoxylin and eosin staining?
Hematoxylin and eosin staining is used to evaluate the tumor cell content in the samples before nucleic acid extraction.
Can this protocol be used for other cancers?
Yes, the protocol can be adapted for use with other types of cancer samples.
繁體中文
